Cat. No. 5244
Chemical Name: 1-Hydroxy-4-methyl-6-(phenylmethyl)
Biological ActivitySelective mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor (Ki = 120-190 nM). Displays >60-fold selectivity for mIDH1 (found in ~75% of gliomas) over wild type IDH1. Also inhibits D-2-hydroxyglutaric acid in cells expressing mIDH1 (EC50 = 2.4 μM). Does not display cytotoxicity towards non-cancerous human cells. Phenotypically lethal.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Zheng et al (2013) Crystallographic investigation and selective inhibition of mutant isocitrate dehydrogenase. ACS Med.Chem.Lett. 4 542. PMID: 23795241.
If you know of a relevant reference for TC-E 5008 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses TC-E 5008 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: TC-E 5008, supplier, TC-E5008, selective, mutant, isocitrate, dehydrogenase, 1, (IDH1), inhibitors, inhibits, phenotypically, lethal, cancer, gliomas, D-2-hydroxyglutaric, acid, Tocris Bioscience, Other Dehydrogenase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective ALDH1A1 inhibitor
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.